Literature DB >> 31018174

Glucocorticoids and programming of the microenvironment in heart.

Rui Song1, Xiang-Qun Hu1, Lubo Zhang1.   

Abstract

Glucocorticoids are primary stress hormones and can improve neonatal survival when given to pregnant women threatened by preterm birth or to preterm infants. It has become increasingly apparent that glucocorticoids, primarily by interacting with glucocorticoid receptors, play a critical role in late gestational cardiac maturation. Altered glucocorticoid actions contribute to the development and progression of heart disease. The knowledge gained from studies in the mature heart or cardiac damage is insufficient but a necessary starting point for understanding cardiac programming including programming of the cardiac microenvironment by glucocorticoids in the fetal heart. This review aims to highlight the potential roles of glucocorticoids in programming of the cardiac microenvironment, especially the supporting cells including endothelial cells, immune cells and fibroblasts. The molecular mechanisms by which glucocorticoids regulate the various cellular and extracellular components and the clinical relevance of glucocorticoid functions in the heart are also discussed.

Entities:  

Keywords:  cardiac development; glucocorticoid; microenvironment; programming

Mesh:

Substances:

Year:  2019        PMID: 31018174      PMCID: PMC6602534          DOI: 10.1530/JOE-18-0672

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  98 in total

Review 1.  Glucocorticoids and fetal programming part 1: Outcomes.

Authors:  Vasilis G Moisiadis; Stephen G Matthews
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

2.  Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.

Authors:  T P Yao; S P Oh; M Fuchs; N D Zhou; L E Ch'ng; D Newsome; R T Bronson; E Li; D M Livingston; R Eckner
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

3.  HDAC2 is required by the physiological concentration of glucocorticoid to inhibit inflammation in cardiac fibroblasts.

Authors:  Haining Zhang; Yanhua He; Guiping Zhang; Xiaobin Li; Suikai Yan; Ning Hou; Qing Xiao; Yue Huang; Miaoshan Luo; Genshui Zhang; Quan Yi; Minsheng Chen; Jiandong Luo
Journal:  Can J Physiol Pharmacol       Date:  2017-05-16       Impact factor: 2.273

Review 4.  Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.

Authors:  Edgar T Jaeggi; Jean-Claude Fouron; Earl D Silverman; Greg Ryan; Jeffrey Smallhorn; Lisa K Hornberger
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

Review 5.  Specificity and sensitivity of glucocorticoid signaling in health and disease.

Authors:  Derek W Cain; John A Cidlowski
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2015-04-25       Impact factor: 4.690

6.  Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization.

Authors:  Bi-Sen Ding; Daniel J Nolan; Peipei Guo; Alexander O Babazadeh; Zhongwei Cao; Zev Rosenwaks; Ronald G Crystal; Michael Simons; Thomas N Sato; Stefan Worgall; Koji Shido; Sina Y Rabbany; Shahin Rafii
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

7.  Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.

Authors:  Karolien De Bosscher; Ilse M Beck; Lien Dejager; Nadia Bougarne; Anthoula Gaigneaux; Sébastien Chateauvieux; Dariusz Ratman; Marc Bracke; Jan Tavernier; Wim Vanden Berghe; Claude Libert; Marc Diederich; Guy Haegeman
Journal:  Cell Mol Life Sci       Date:  2013-06-20       Impact factor: 9.261

8.  Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Wilfred C de Vega; Santiago Herrera; Suzanne D Vernon; Patrick O McGowan
Journal:  BMC Med Genomics       Date:  2017-02-23       Impact factor: 3.063

Review 9.  The role of microRNAs in glucocorticoid action.

Authors:  Sally A Clayton; Simon W Jones; Mariola Kurowska-Stolarska; Andrew R Clark
Journal:  J Biol Chem       Date:  2018-01-04       Impact factor: 5.157

Review 10.  Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation.

Authors:  Emma J Agnew; Jessica R Ivy; Sarah J Stock; Karen E Chapman
Journal:  J Mol Endocrinol       Date:  2018-05-02       Impact factor: 5.098

View more
  4 in total

1.  Developmental programming of DNA methylation and gene expression patterns is associated with extreme cardiovascular tolerance to anoxia in the common snapping turtle.

Authors:  Ilan Ruhr; Jacob Bierstedt; Turk Rhen; Debojyoti Das; Sunil Kumar Singh; Soleille Miller; Dane A Crossley; Gina L J Galli
Journal:  Epigenetics Chromatin       Date:  2021-09-06       Impact factor: 4.954

Review 2.  The role of hormones and neurons in cardiomyocyte maturation.

Authors:  Emmanouil Tampakakis; Ahmed I Mahmoud
Journal:  Semin Cell Dev Biol       Date:  2021-04-28       Impact factor: 7.499

3.  Impact of maternal prenatal stress by glucocorticoids on metabolic and cardiovascular outcomes in their offspring: A systematic scoping review.

Authors:  Claudia Eberle; Teresa Fasig; Franziska Brüseke; Stefanie Stichling
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

4.  Glucocorticoid stimulation increases cardiac contractility by SGK1-dependent SOCE-activation in rat cardiac myocytes.

Authors:  Michael Wester; Anton Heller; Michael Gruber; Lars S Maier; Christian Schach; Stefan Wagner
Journal:  PLoS One       Date:  2019-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.